Iterative development of MobileMums: a physical activity intervention for women with young children

<p>Abstract</p> <p>Background</p> <p>To describe the iterative development process and final version of 'MobileMums': a physical activity intervention for women with young children (<5 years) delivered primarily via mobile telephone (mHealth) short messagin...

Full description

Saved in:
Bibliographic Details
Main Authors: Fjeldsoe Brianna S (Author), Miller Yvette D (Author), O'Brien Jasmine L (Author), Marshall Alison L (Author)
Format: Book
Published: BMC, 2012-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<p>Abstract</p> <p>Background</p> <p>To describe the iterative development process and final version of 'MobileMums': a physical activity intervention for women with young children (<5 years) delivered primarily via mobile telephone (mHealth) short messaging service (SMS).</p> <p>Methods</p> <p>MobileMums development followed the five steps outlined in the mHealth development and evaluation framework: 1) conceptualization (critique of literature and theory); 2) formative research (focus groups, n= 48); 3) pre-testing (qualitative pilot of intervention components, n= 12); 4) pilot testing (pilot RCT, n= 88); and, 5) qualitative evaluation of the refined intervention (n= 6).</p> <p>Results</p> <p>Key findings identified throughout the development process that shaped the MobileMums program were the need for: behaviour change techniques to be grounded in Social Cognitive Theory; tailored SMS content; two-way SMS interaction; rapport between SMS sender and recipient; an automated software platform to generate and send SMS; and, flexibility in location of a face-to-face delivered component.</p> <p>Conclusions</p> <p>The final version of MobileMums is flexible and adaptive to individual participant's physical activity goals, expectations and environment. MobileMums is being evaluated in a community-based randomised controlled efficacy trial (ACTRN12611000481976).</p>
Item Description:10.1186/1479-5868-9-151
1479-5868